Medication Adherence Its Importance in Cardiovascular Outcomes

被引：1124

作者：

Ho, P. Michael ^{[1
,2
,3
]}

Bryson, Chris L. ^{[4
,5
]}

Rumsfeld, John S. ^{[1
,2
,3
]}

机构：

[1] Denver VA Med Ctr, Denver, CO USA

[2] Univ Colorado, Denver, CO 80202 USA

[3] Kaiser Permanente, Inst Hlth Res, Aurora, CO USA

[4] Puget Sound VA Med Ctr, Seattle, WA USA

[5] Univ Washington, Seattle, WA 98195 USA

来源：

CIRCULATION | 2009年 / 119卷 / 23期

关键词：

cardiovascular diseases; healthcare quality assessment; medication adherence; outcomes research; ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL-INFARCTION; EVIDENCE-BASED PHARMACOTHERAPY; RANDOMIZED CONTROLLED-TRIALS; CHRONIC HEART-FAILURE; LONG-TERM MORTALITY; DEPRESSIVE SYMPTOMS; BLOOD-PRESSURE; DRUG-THERAPY; ANTIHYPERTENSIVE MEDICATION;

D O I：

10.1161/CIRCULATIONAHA.108.768986

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Medication adherence usually refers to whether patients take their medications as prescribed (eg, twice daily), as well as whether they continue to take a prescribed medication. Medication nonadherence is a growing concern to clinicians, healthcare systems, and other stakeholders (eg, payers) because of mounting evidence that it is prevalent and associated with adverse outcomes and higher costs of care. To date, measurement of patient medication adherence and use of interventions to improve adherence are rare in routine clinical practice. The goals of the present report are to address (1) different methods of measuring adherence, (2) the prevalence of medication nonadherence, (3) the association between nonadherence and outcomes, (4) the reasons for nonadherence, and finally, (5) interventions to improve medication adherence. (Circulation. 2009; 119: 3028-3035.)

引用

页码：3028 / 3035

页数：8

共 79 条

[1] Methods for evaluation of medication adherence and persistence using automated databases
Andrade, Susan E.
Kahler, Kristijan H.
Frech, Feride
Chan, K. Arnold
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (08) : 565 - 574
[2] [Anonymous], 2005, ADHERENCE LONG TERM
[3] The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease
Bane, C
Hughes, CM
McElnay, JC
[J]. PATIENT EDUCATION AND COUNSELING, 2006, 60 (02) : 187 - 193
[4] Factors associated with adherence to drug therapy:: a population-based study
Bardel, Annika
Wallander, Mari-Ann
Svardsudd, Kurt
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) : 307 - 314
[5] How do providers assess antihypertensive medication adherence in medical encounters?
Bokhour, Barbara G.
Berlowitz, Dan R.
Long, Judith A.
Kressin, Nancy R.
[J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 (06) : 577 - 583
[6] Relationship of blood pressure control to adherence with anti hypertensive monotherapy in 13 managed care organizations
Bramley, TJ
Gerbino, PP
Nightengale, BS
Frech-Tamas, F
[J]. JOURNAL OF MANAGED CARE PHARMACY, 2006, 12 (03): : 239 - 245
[7] Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
Brookhart, M. Alan
Patrick, Amanda R.
Dormuth, Colin
Avorn, Jerry
Shrank, William
Cadarette, Suzanne M.
Solomon, Daniel H.
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 166 (03) : 348 - 354
[8] A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp)
Bryson, Chris L.
Au, David H.
Young, Bessie
McDonell, Mary B.
Fihn, Stephan D.
[J]. MEDICAL CARE, 2007, 45 (06) : 497 - 504
[9] Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization
Caetano, Patricia A.
Lam, Jonathan M. C.
Morgan, Steven G.
[J]. CLINICAL THERAPEUTICS, 2006, 28 (09) : 1411 - 1424
[10] CANNER PL, 1980, NEW ENGL J MED, V303, P1038

← 1 2 3 4 5 6 7 8 →